Efficacy and Safety of Ipragliflozin (IPRA) in Japanese Patients with Type 2 Diabetes Mellitus (T2DM) Stratified by Body Mass Index (BMI)

被引:0
作者
Kashiwagi, Atsunori
Yoshida, Satoshi
Nakamura, Ichiro
Kazuta, Kenichi
Ueyama, Eiji
Takahashi, Hideyuki
Satomi, Hayato
Kosakai, Yoshinori
Kawamuki, Kousei
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1197-P
引用
收藏
页码:A309 / A309
页数:1
相关论文
共 50 条
[31]   Efficacy of low dose sibutramine in obese type-2 diabetes mellitus (T2DM) Indian patients [J].
Gupta, Ashwani K. ;
Badyal, Dinesh K. ;
Matreja, Prithpal S. ;
Khosla, Prem P. ;
John, Mary .
WORLD FAMILY MEDICINE, 2012, 10 (03) :29-35
[32]   Safety and Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus (T2DM) in South Korea [J].
Kim, Hun-Sung ;
Min, Kyungwan ;
Kim, Sang Soo ;
Kim, Eun Sook ;
Chung, Yoon-Sok ;
Chung, Choon H. ;
Yun, Jae-Seung ;
Kim, Won ;
Kim, Dong Han ;
Yoo, Soon Jib .
DIABETES, 2024, 73
[33]   Inappropriate metformin prescribing in elderly type 2 diabetes mellitus (T2DM) patients [J].
Kosmalski, M. ;
Drozdowska, A. ;
Sliwinska, A. ;
Drzewoski, J. .
ADVANCES IN MEDICAL SCIENCES, 2012, 57 (01) :65-70
[34]   Cause of Hospitalizations in Patients with Type 2 Diabetes Mellitus (T2DM) in the CANVAS Program [J].
Mahaffey, Kenneth W. ;
Ianus, Juliana ;
Damaraju, C. V. ;
Neal, Bruce ;
De Zeeuw, Dick ;
Fulcher, Greg ;
Pfeifer, Michael ;
Matthews, David R. .
DIABETES, 2019, 68
[35]   Characteristics of Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Therapy with Canagliflozin [J].
Martin, Silas C. ;
Henk, Henry J. ;
Chow, Wing .
DIABETES, 2014, 63 :A307-A307
[36]   MobiDiabet: Mobile Telemonitoring System for Patients with Type 2 Diabetes Mellitus (T2DM) [J].
Alcala Juarez, Anakaren ;
Hernandez Villegas, Manuel Alejandro ;
Dominguez, Eduardo Lopez ;
Hernandez Velazquez, Yesenia ;
Dominguez Isidro, Saul ;
Ovando Diego, Liliana ;
Hernandez Sanchez, Olivia ;
De La Calleja, Jorge ;
Pomares Hernandez, Saul Eduardo ;
Medina Nieto, Maria Auxilio .
APPLIED SCIENCES-BASEL, 2020, 10 (22) :1-36
[37]   Development and Validation of Yoga Program for Patients with Type 2 Diabetes Mellitus (T2DM) [J].
Thulasi, Arun ;
Kumar, Vinod ;
Jagannathan, Aarti ;
Angadi, Praveen ;
Umamaheswar, Kundapur ;
Raghuram, Nagarathna .
JOURNAL OF RELIGION & HEALTH, 2022, 61 (03) :1951-1965
[38]   Development and Validation of Yoga Program for Patients with Type 2 Diabetes Mellitus (T2DM) [J].
Arun Thulasi ;
Vinod Kumar ;
Aarti Jagannathan ;
Praveen Angadi ;
Kundapur Umamaheswar ;
Nagarathna Raghuram .
Journal of Religion and Health, 2022, 61 :1951-1965
[39]   Empagliflozin in Patients With Type 2 Diabetes Mellitus (T2DM) and Renal Impairment (RI) [J].
Barnett, Anthony H. ;
Mithal, Ambrish ;
Manassie, Jenny ;
Jones, Russell ;
Rattunde, Henning ;
Woerle, Hans J. ;
Broedl, Uli C. .
DIABETES, 2013, 62 :A286-A286
[40]   Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes and inadequate glycaemic control on sitagliptin [J].
Kaku, Kohei ;
Kadowaki, Takashi ;
Seino, Yutaka ;
Okamoto, Taro ;
Shirakawa, Masayoshi ;
Sato, Asako ;
O'Neill, Edward A. ;
Engel, Samuel S. ;
Kaufman, Keith D. .
DIABETES OBESITY & METABOLISM, 2021, 23 (09) :2099-2108